Sanofi board approves demerger of its consumer healthcare business

Drug firm Sanofi India on Wednesday said its board has approved the demerger of its consumer healthcare business into a separate entity. The company's board has approved the Scheme of Arrangement between Sanofi India Ltd (SIL) and its wholly-owned subsidiary Sanofi Consumer Healthcare India Ltd (SCHIL), the drug maker said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/DWIVnhg
via IFTTT